Richmond firm changes name to Accendra Health, will trade as ACH on NYSE while keeping Apria and Byram Healthcare brands ...

A fourth delay hits Staar Surgical’s shareholder vote on Alcon's $1.6B takeover as Broadwood Partners calls the deal flawed ...

FDA loses two key leaders as Jessica Paulsen departs Digital Health Center and David McMullen joins Neuralink amid staffing ...

CMR Surgical has received FDA clearance for its Versius Plus surgical robotic platform. The clearance covers cholecystectomy ...

J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.

Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.

FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the United States.

Comparative trials are among the hardest studies to execute in medtech, especially when the control arm is a long-established ...

David Fischel, Stereotaxis CEO, talks about the market opportunity for the company’s surgical robotic solutions.

Edwards pushes CMS to expand Medicare TAVR coverage as agency opens public comment period through January 2026 for decision.

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals ...